跳至主要内容
临床试验/ACTRN12611000444987
ACTRN12611000444987已完成1 期

The possible effect of gestational antioxidant on coagulopathy associated preeclampsia in women at risk of preeclampsia

magdy ameen elkady0 个研究点目标入组 251 人开始时间: 2011年5月2日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
251

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
24 Years 至 35 Years(—)
性别
Female

入选标准

  • Only pregnant women with high risk for pre-eclampsia were considered. The inclusion criteria were gestational age between 6-10 weeks with one or more of the following risk factors: pre-eclampsia in the pregnancy preceding the current one, eclampsia in any previous pregnancy, essential hypertension requiring medication, diagnosis of HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count), and chronic renal disease pre-pregnancy or during pregnancy

排除标准

  • . Exclusion criteria included maternal liver disease, diabetes mellitus and possible materno-fetal fetus Rh incompatibility.

研究者

发起方
magdy ameen elkady

相似试验